Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012;7(8):e41941.
doi: 10.1371/journal.pone.0041941. Epub 2012 Aug 1.

Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis

Affiliations
Meta-Analysis

Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis

Jeffrey M Cohen et al. PLoS One. 2012.

Abstract

Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has been treated with several different interventions with limited success. This meta-analysis aims to review all trials reporting on therapeutic intervention for CP/CPPS using the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI).

Methods: We searched Medline, PubMed, the Cochrane Pain, Palliative & Supportive Care Trials, the Cochrane Register of Controlled Trials, CINAHL, ClinicalTrials.gov, and the NIDDK website between 1947 and December 31, 2011 without language or study type restrictions. All RCTs for CP/CPPS lasting at least 6 weeks, with a minimum of 10 participants per arm, and using the NIH-CPSI score, the criterion standard for CP/CPPS, as an outcome measure were included. Data was extracted from each study by two independent reviewers. Gillbraith and I-squared plots were used for heterogeneity testing and Eggers and Peters methods for publication bias. Quality was assessed using a component approach and meta-regression was used to analyze sources of heterogeneity.

Results: Mepartricin, percutaneous tibial nerve stimulation (PTNS), and triple therapy comprised of doxazosin + ibuprofen + thiocolchicoside (DIT) resulted in clinically and statistically significant reduction in NIH-CPSI total score. The same agents and aerobic exercise resulted in clinically and statistically significant NIH-CPSI pain domain score reduction. Acupuncture, DIT, and PTNS were found to produce statistically and clinically significant reductions in the NIH-CPSI voiding domain. A statistically significant placebo effect was found for all outcomes and time analysis showed that efficacy of all treatments increased over time. Alpha-blockers, antibiotics, and combinations of the two failed to show statistically or clinically significant NIH-CPSI reductions.

Conclusion: Results from this meta-analysis reflect our current inability to effectively manage CP/CPPS. Clinicians and researchers must consider placebo effect and treatment efficacy over time and design studies creatively so we can more fully elucidate the etiology and role of therapeutic intervention in CP/CPPS.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Reviewer Adjudication Strategy.
Figure 2
Figure 2. Study Selection Strategy.
Figure 3
Figure 3. Forest Plot of Changes in the total NIH-CPSI Score.
Figure 4
Figure 4. Forest Plot of Changes in the NIH-CPSI Pain Domain Score.
Figure 5
Figure 5. Forest Plot of Changes in the NIH-CPSI Voiding Score.
Figure 6
Figure 6. Forest Plot of Changes in the NIH-CPSI QoL Score.

References

    1. Krieger JN, Nyberg L, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282: 236–237. - PubMed
    1. Engeler D, Baranowski A, Elneil S, Hughes J, Messelink E, et al. (2012) Guidelines on chronic pelvic pain. European Association of Urology. - PubMed
    1. McNaughton Collins M, MacDonald R, Wilt TJ (2000) Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann Intern Med 133: 367–381. - PubMed
    1. Litwin M, McNaughton-Collins M, Fowler FJ, Nickel J, Calhoun E, et al. (1999) The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 162: 369–375. - PubMed
    1. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Group TP (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 3: e123–e130. - PMC - PubMed